2011

Welcome to Volume 10, Issue #13 (23 AUGUST 2011) of Pharma Marketing News.

In a recent video titled 'What Gets PhRMA's Chairman Up Every Morning?', Chris Viehbacher, CEO of Sanofi, cited an impressive Potemkin number related to life expectancy and the pharma industry.

A conversation with Mark Bard, founder of the Digital Health Coalition, regarding the mission of the Coalition and what companies and individuals are involved.

Welcome to Volume 10, Issue #11 (21 JUNE 2011) of Pharma Marketing News.

The Death of the Traditional Pharma Salesman and the Birth of the 'Sales Cyborg.' eDetailing in one form or another seems to be making a comeback since the recession hit the drug industry in 2007 and 2008. Which is the 'chicken' and which is the 'egg'? Did the uptick in adoption of eDetailing technology lead to the recent layoff of pharma reps or were reps laid off because of the economy and subsequently replaced by machines?

Welcome to Volume 10, Issue #4 (23 FEBRUARY 2011) of Pharma Marketing News.

David Epstein, head of Novartis Pharmaceuticals, said eighty percent of his company's sales reps will give up their PCs for iPads in 2012. Will they do it?

More and more pharmaceutical company employees are using Twitter. Pharmaguy is looking at pharma employees who have personal Twitter accounts, how they use these accounts, who follows them and whom they follow, and how influential they are. This article is an introduction to the first round of members of this group.

Welcome to Volume 10, Issue #19 (21 DECEMBER 2011) of Pharma Marketing News.

Economic Experts Disagree Wildly on How Much It Costs to Bring a New Drug to Market. How is it that the Tufts estimate is at least 14 TIMES the London School of Economics and Political Science (LSEPS) estimate? 'Make no mistake,' said Tufts. 'Tufts CSDD will vigorously defend the scholarship, integrity, and validity of all its published research studies.'